Prominent role of NF-κB in the induction of endothelial activation by endogenous nitric oxide inhibition

Nitric Oxide - Biology and Chemistry

Volumn 21, Issue 3-4, 2009, Pages 184-191

  Lazzerini, Guido ^a   Turco, Serena Del ^a   Basta, Giuseppina ^a   O'Loghlen, Ana ^a,b   Zampolli, Antonella ^c   Caterina, Raffaele De ^c  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Adhesion molecules; Endothelial activation; Nitric oxide; Nuclear factor B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1ALPHA; MESSENGER RNA; N(G) METHYLARGININE; NITRIC OXIDE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR GATA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ACTIVATION; CELL ADHESION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UMBILICAL VEIN;

ATHEROSCLEROSIS; CELLS, CULTURED; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GATA TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON REGULATORY FACTOR-1; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTOR AP-1; VASCULAR CELL ADHESION MOLECULE-1;

EID: 71849108700     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2009.07.007     Document Type: Article

References (44)

1. Libby P. Atherosclerosis: the new view. Sci. Am. 286 5 (2002) 46-55
2. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., Davis V., Gutierrez-Ramos J.C., Connelly P.W., and Milstone D.S. A major role for VCAM-1, but not ICAM-1. In early atherosclerosis. J. Clin. Invest. 107 10 (2001) 1255-1262
3. Iademarco M.F., McQuillan J.J., Rosen G.D., and Dean D.C. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267 23 (1992) 16323-16329
4. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., and Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9 10 (1995) 899-909
5. Nakaki T., Nakayama M., and Kato R. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur. J. Pharmacol. 189 6 (1990) 347-353
6. De Caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone Jr. M.A., Shin W.S., and Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96 1 (1995) 60-68
7. Tsao P.S., Buitrago R., Chan J.R., and Cooke J.P. Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1. Circulation 94 7 (1996) 1682-1689
8. Nabah Y.N., Mateo T., Cerda-Nicolas M., Alvarez A., Martinez M., Issekutz A.C., and Sanz M.J. L-NAME induces direct arteriolar leukocyte adhesion, which is mainly mediated by angiotensin-II. Microcirculation 12 5 (2005) 443-453
9. Leiper J., and Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc. Res. 43 3 (1999) 542-548
10. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 100 9 (1997) 2153-2157
11. Arnal J.F., Dinh-Xuan A.T., Pueyo M., Darblade B., and Rami J. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell. Mol. Life Sci. 55 8-9 (1999) 1078-1087
12. Fischer S., Clauss M., Wiesnet M., Renz D., Schaper W., and Karliczek G.F. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. Am. J. Physiol. 276 4 Pt. 1 (1999) C812-C820
13. Davis M.E., Cai H., Drummond G.R., and Harrison D.G. Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways. Circ. Res. 89 11 (2001) 1073-1080
14. Simoncini T., Maffei S., Basta G., Barsacchi G., Genazzani A.R., Liao J.K., and De Caterina R. Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ. Res. 87 1 (2000) 19-25
15. Gelinas D.S., Bernatchez P.N., Rollin S., Bazan N.G., and Sirois M.G. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways. Br. J. Pharmacol. 137 7 (2002) 1021-1030
16. Zampolli A., Basta G., Lazzerini G., Feelisch M., and De Caterina R. Inhibition of endothelial cell activation by nitric oxide donors. J. Pharmacol. Exp. Ther. 295 2 (2000) 818-823
17. Sabrane K., Gambaryan S., Brandes R.P., Holtwick R., Voss M., and Kuhn M. Increased sensitivity to endothelial nitric oxide (NO) contributes to arterial normotension in mice with vascular smooth muscle-selective deletion of the atrial natriuretic peptide (ANP) receptor. J. Biol. Chem. 278 20 (2003) 17963-17968
18. Khan B.V., Harrison D.G., Olbrych M.T., Alexander R.W., and Medford R.M. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc. Natl. Acad. Sci. USA 93 17 (1996) 9114-9119
19. Isenberg J.S. Inhibition of nitric oxide synthase (NOS) conversion of l-arginine to nitric oxide (NO) decreases low density mononuclear cell (LD MNC) trans-endothelial migration and cytokine output. J. Surg. Res. 114 1 (2003) 100-106
20. Spiecker M., Peng H.B., and Liao J.K. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J. Biol. Chem. 272 49 (1997) 30969-30974
21. Massaro M., Carluccio M.A., Paolicchi A., Bosetti F., Solaini G., and De Caterina R. Mechanisms for reduction of endothelial activation by oleate: inhibition of nuclear factor-kappaB through antioxidant effects. Prostaglandins Leukot. Essent. Fatty Acids 67 2-3 (2002) 175-181
22. Pober J.S., Gimbrone Jr. M.A., Lapierre L.A., Mendrick D.L., Fiers W., Rothlein R., and Springer T.A. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137 6 (1986) 1893-1896
23. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126 1 (1982) 131-138
24. De Caterina R., Cybulsky M.I., Clinton S.K., Gimbrone Jr. M.A., and Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler. Thromb. 14 11 (1994) 1829-1836
25. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 5 (1983) 1475-1489
26. Pizzorusso T., Ratto G.M., Putignano E., and Maffei L. Brain-derived neurotrophic factor causes cAMP response element-binding protein phosphorylation in absence of calcium increases in slices and cultured neurons from rat visual cortex. J. Neurosci. 20 8 (2000) 2809-2816
27. Basta G., Lazzerini G., Del Turco S., Ratto G.M., Schmidt A.M., and De Caterina R. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler. Thromb. Vasc. Biol. 25 7 (2005) 1401-1407
28. Searles C.D., Miwa Y., Harrison D.G., and Ramasamy S. Posttranscriptional regulation of endothelial nitric oxide synthase during cell growth. Circ. Res. 85 7 (1999) 588-595
29. Waldow T., Witt W., Weber E., and Matschke K. Nitric oxide donor-induced persistent inhibition of cell adhesion protein expression and NFkappaB activation in endothelial cells. Nitric oxide 15 2 (2006) 103-113
30. Shu H.B., Agranoff A.B., Nabel E.G., Leung K., Duckett C.S., Neish A.S., Collins T., and Nabel G.J. Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endothelial and epithelial cells. Mol. Cell. Biol. 13 10 (1993) 6283-6289
31. Ahmad M., Theofanidis P., and Medford R.M. Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha. J. Biol. Chem. 273 8 (1998) 4616-4621
32. Franek W.R., Chowdary Y.C., Lin X., Hu M., Miller E.J., Kazzaz J.A., Razzano P., Romashko 3rd J., Davis J.M., Narula P., Horowitz S., Scott W., and Mantell L.L. Suppression of nuclear factor-kappa B activity by nitric oxide and hyperoxia in oxygen-resistant cells. J. Biol. Chem. 277 45 (2002) 42694-42700
33. Koh Y., Kang J.L., Park W., Pack I.S., Lee H.S., Kim M.J., and Lim C.M. Inhaled nitric oxide down-regulates intrapulmonary nitric oxide production in lipopolysaccharide-induced acute lung injury. Crit. Care Med. 29 6 (2001) 1169-1174
34. Mariotto S., Cuzzolin L., Adami A., Del Soldato P., Suzuki H., and Benoni G. Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils. Br. J. Pharmacol. 114 6 (1995) 1105-1106
35. Matthews J.R., Botting C.H., Panico M., Morris H.R., and Hay R.T. Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res. 24 12 (1996) 2236-2242
36. Colasanti M., and Suzuki H. The dual personality of NO. Trends Pharmacol. Sci. 21 7 (2000) 249-252
37. Colasanti M., Persichini T., Menegazzi M., Mariotto S., Giordano E., Caldarera C.M., Sogos V., Lauro G.M., and Suzuki H. Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J. Biol. Chem. 270 45 (1995) 26731-26733
38. Nikitovic D., Holmgren A., and Spyrou G. Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos. Biochem. Biophys. Res. Commun. 242 1 (1998) 109-112
39. Minami T., Miura M., Aird W.C., and Kodama T. Thrombin-induced autoinhibitory factor, Down syndrome critical region-1, attenuates NFAT-dependent vascular cell adhesion molecule-1 expression and inflammation in the endothelium. J. Biol. Chem. 281 29 (2006) 20503-20520
40. De Caterina R., Bourcier T., Laufs U., La Fata V., Lazzerini G., Neish A.S., Libby P., and Liao J.K. Induction of endothelial-leukocyte interaction by interferon-gamma requires coactivation of nuclear factor-kappaB. Arterioscler. Thromb. Vasc. Biol. 21 2 (2001) 227-232
41. Shinozaki K., Kashiwagi A., Nishio Y., Okamura T., Yoshida Y., Masada M., Toda N., and Kikkawa R. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2-imbalance in insulin-resistant rat aorta. Diabetes 48 12 (1999) 2437-2445
42. Evans M., Khan N., and Rees A. Diabetic dyslipidaemia and coronary heart disease: new perspectives. Curr. Opin. Lipidol. 10 5 (1999) 387-391
43. Kusterer K., Pohl T., Fortmeyer H.P., Marz W., Scharnagl H., Oldenburg A., Angermuller S., Fleming I., Usadel K.H., and Busse R. Chronic selective hypertriglyceridemia impairs endothelium-dependent vasodilatation in rats. Cardiovasc. Res. 42 3 (1999) 783-793
44. Xu B., Chibber R., Ruggiero D., Kohner E., Ritter J., and Ferro A. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J. 17 10 (2003) 1289-1291